[Intravesical therapy: Influence on superficial bladder cancer recurrence].
OBJECTIVE
To review the influence of various intravesical treatments on superficial bladder cancer recurrence.


METHODS
We retrospectively reviewed 473 superficial bladder neoplasias. Based on diagnosis and transurethral resection of bladder tumor (TUR BT), and depending on pathology, we proposed different adjuvant treatment and follow-up schemes.


RESULTS
The following factors were independent risk factors for a longer recurrence-free time: intravesical instillations, high dose BCG, and maintenance therapy in comparison to induction.


CONCLUSIONS
The use of intravesical instillations independently increases the time to recurrence. It was demonstrated that recurrence was significantly later when high dose BCG and maintenance therapy were employed.
García Rodríguez
Jorge
J
Servicio de Urología I, Hospital Central de Asturias, Oviedo, Asturias, España. jgrmed@hotmail.com
Fernández Gómez
Jesús María
JM
Escaf Barmadah
Safwan
S
González Alvarez
Roberto Carlos
RC
Jalón Monzón
Antonio
A
Martínez Gómez
Francisco Javier
FJ
Sánchez Trilla
Alberto
A
Regadera Sejas
Javier
J
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001500:BCG Vaccine / Q000008:administration & dosage*; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D012189:Retrospective Studies; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D016685:Mitomycin